Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Abbvie Company Banner

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Abbvie Company Banner

06

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Abbvie Company Banner

07

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : RE43879

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2026-01-11

Abbvie Company Banner

08

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8481598

Drug Substance Claim :

Drug Product Claim :

Application Number : 204168

Patent Use Code : U-839

Delist Requested :

Patent Use Description : TREATMENT OF MAJOR DEP...

Patent Expiration Date : 2031-03-02

Abbvie Company Banner

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8865937

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204168

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-05-23

Abbvie Company Banner

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

LEVOMILNACIPRAN HYDROCHLORIDE

US Patent Number : 8865937

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204168

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-05-23

Abbvie Company Banner